TO DEGRADE OF NOT DEGRADE: TARGETING THE ANDROGEN RECEPTOR IN AR-DEPENDENT PROSTATE CANCER

$544,324FY2008Department of the ArmyDOD

Baylor College Of Medicine, Houston TX

Investigators